Vaccine Safety and DMT for Highly Active MS: New Data
Immunization with inactivated vaccines while receiving the disease-modifying therapy natalizumab for highly active multiple sclerosis (MS) is safe and immunogenic, with no increased risk for disease progression, new research shows. The study, the first to …